4//SEC Filing
Johnson Kevin C 4
Accession 0001077183-20-000219
CIK 0001077183other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 6:19 PM ET
Size
8.3 KB
Accession
0001077183-20-000219
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Sale
Common Stock
2020-12-04$47.88/sh−24,683$1,181,822→ 30,983 total
Holdings
- 3,334
Stock Options (Right to Buy)
Exercise: $7.27Exp: 2022-05-25→ Common Stock (3,334 underlying) - 4,269
Stock Options (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,448
Stock Options (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001353436
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 6:19 PM ET
- Size
- 8.3 KB